GSC
CVS icon

G&S Capital’s CVS Health CVS Stock Holding History

G&S Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,969
Closed -$973K – 83
2020
Q2 		$973K Buy
14,969
+14,292
+2,111% +$900K 0.87% 32
2020
Q1 		$40K Hold
677
– – 0.07% 100
2019
Q4 		$50K Hold
677
– – 0.03% 139
2019
Q3 		$43K Sell
677
-323
-32% -$19.1K 0.03% 121
2019
Q2 		$54K Hold
1,000
– – 0.03% 125
2019
Q1 		$54K Hold
1,000
– – 0.03% 116
2018
Q4 		$66K Hold
1,000
– – 0.06% 88
2018
Q3 		$79K Hold
1,000
– – 0.05% 103
2018
Q2 		$64K Hold
1,000
– – 0.05% 103
2018
Q1 		$62K Hold
1,000
– – 0.05% 101
2017
Q4 		$73K Buy
+1,000
New +$72.7K 0.05% 115

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

G&S Capital's CVS Position: Q3 2020 in Review

G&S Capital sold out of CVS Health (CVS) in Q3 2020, closing a stake of 14,969 shares — an estimated $973K sold.

G&S Capital first reported a position in CVS in Q4 2017 and held it in 11 quarters. The position peaked at $973K in Q2 2020. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • G&S Capital reported no remaining CVS Health position as of Q3 2020 after selling out during the quarter.
  • G&S Capital sold 14,969 CVS Health shares in Q3 2020, an estimated $973K.
  • G&S Capital first reported a position in CVS Health in Q4 2017 and held it in 11 quarters.
  • G&S Capital's CVS Health position peaked at $973K in Q2 2020.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on G&S Capital's 13F filing for Q3 2020, filed 21 Oct 2020.